Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code
x Close Forever Close
Volume 24 Issue 2
. 
Turn off MathJax
Article Contents
Article Navigation >  Journal of Pharmaceutical Practice and Service  > 2006  >  (2): 107-108

WU Xue, LI Chuan-mei, QIAO Hua-min. The cost-effectiveness analysis of irbesartan and benazepril in treating primary hypertension[J]. Journal of Pharmaceutical Practice and Service, 2006, (2): 107-108.
Citation: WU Xue, LI Chuan-mei, QIAO Hua-min. The cost-effectiveness analysis of irbesartan and benazepril in treating primary hypertension[J]. Journal of Pharmaceutical Practice and Service, 2006, (2): 107-108.
shu

The cost-effectiveness analysis of irbesartan and benazepril in treating primary hypertension

  • The 181th Hospital of PLA, Guilin 541002, China

  • Received Date: 2005-08-26
  • Objective : To evaluate cost-effectiveness of irbesartan and benazepril in the treatment of primary hypertension. Methods : According to literatures and method of cost-effectiveness analysis, two drugs with the treatment of primary hypertension were eco-nomicaly evaluated. Results and Conclusion : There were no obvious difference between these two projects in treating primary hypertension.The cost of treatment of two drugs were 998.68 and 923.08 yuan.The cost-effectiveness ratio of benazepril is superior to that of irbesartan.
  • 加载中
通讯作者: 陈斌, [email protected]
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Get Citation
PDF
XML

Article Metrics

Article views(2378) PDF downloads(149) Cited by()

Related
Proportional views

The cost-effectiveness analysis of irbesartan and benazepril in treating primary hypertension

  • The 181th Hospital of PLA, Guilin 541002, China
  • Received Date: 2005-08-26

Abstract: Objective : To evaluate cost-effectiveness of irbesartan and benazepril in the treatment of primary hypertension. Methods : According to literatures and method of cost-effectiveness analysis, two drugs with the treatment of primary hypertension were eco-nomicaly evaluated. Results and Conclusion : There were no obvious difference between these two projects in treating primary hypertension.The cost of treatment of two drugs were 998.68 and 923.08 yuan.The cost-effectiveness ratio of benazepril is superior to that of irbesartan.

WU Xue, LI Chuan-mei, QIAO Hua-min. The cost-effectiveness analysis of irbesartan and benazepril in treating primary hypertension[J]. Journal of Pharmaceutical Practice and Service, 2006, (2): 107-108.
Citation: WU Xue, LI Chuan-mei, QIAO Hua-min. The cost-effectiveness analysis of irbesartan and benazepril in treating primary hypertension[J]. Journal of Pharmaceutical Practice and Service, 2006, (2): 107-108.
shu

    HTML

Catalog

    版权所有：《药学实践与服务》编辑委员会

    Supervisor & Sponsors: Address: No 325 Guohe Road, ShanghaiPost Code: 200433

    Tel: （021）81871324,81871397 E-mail: [email protected]

    网站备案号 沪ICP备05003363号-1

    Supported by: Beijing Renhe Information Technology Co., Ltd.  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return